| Outgoing Relation(s) |
| EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) is a EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitor (CHEBI:76808) |
| Incoming Relation(s) |
| 3-carboxyphenyl phenylacetamidomethylphosphonate (CHEBI:10586) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| 7,8-dihydroxy-1-methoxy-3-methyl-10-oxo-1H,10H-pyrano[4,3-b]chromene-9-carboxylic acid (CHEBI:68710) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| 7,8-dihydroxy-1-methoxy-3-methyl-10-oxo-4,10-dihydro-1H,3H-pyrano[4,3-b]chromene-9-carboxylic acid (CHEBI:68709) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| 7,8-dihydroxy-3-methyl-10-oxo-10H-chromeno[3,2-c]pyridine-9-carboxylic acid (CHEBI:68708) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| avibactam (CHEBI:85984) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| avibactam sodium (CHEBI:85982) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| ceftriaxone (CHEBI:29007) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| clavulanic acid (CHEBI:48947) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| durlobactam (CHEBI:229539) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| durlobactam sodium (CHEBI:229544) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| potassium clavulanate (CHEBI:85264) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| salsalate (CHEBI:9014) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| tazobactam (CHEBI:9421) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| tazobactam sodium (CHEBI:85192) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
| xacduro (CHEBI:229547) has role EC 3.5.2.6 (β-lactamase) inhibitor (CHEBI:35625) |
